SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+11.7%
5Y CAGR+9.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+11.7%/yr
vs +5.9%/yr prior
5Y CAGR
+9.7%/yr
Consistent
Acceleration
+5.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $132.05B | +4.6% |
| 2024 | $126.30B | +18.5% |
| 2023 | $106.63B | +12.4% |
| 2022 | $94.87B | +5.3% |
| 2021 | $90.07B | +8.2% |
| 2020 | $83.24B | +3.8% |
| 2019 | $80.16B | +6.2% |
| 2018 | $75.48B | +5.2% |
| 2017 | $71.74B | +0.6% |
| 2016 | $71.32B | - |